Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks
The company hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, inaugurated in 2024
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
